Cilnidipine, a novel calcium antagonist accompanied with Ltype and N-type calcium channel blocking function, is mainly used for treatment of hypertension. Due to its N-type calcium channel blocking properties, it has more advantages compared to conventional calcium channel blockers. The present investigation is aimed to formulate a pulsatile drug delivery system with a lag time of about 6 hr. C...
